BRIEF RESEARCH REPORT article
Front. Immunol.
Sec. Autoimmune and Autoinflammatory Disorders : Autoimmune Disorders
Volume 16 - 2025 | doi: 10.3389/fimmu.2025.1661851
This article is part of the Research TopicCell Models and Preclinical Validation of Immune-Mediating Biological TherapiesView all 3 articles
Introducing human 3D skin models as a new serological diagnostic tool for severe autoimmune bullous diseases
Provisionally accepted- 1Department of Dermatology and Allergology, Uniklinik RWTH Aachen, Aachen, Germany
- 2DWI-Leibniz-Institut fur Interaktive Materialien, Aachen, Germany
- 3CTC-A - Center for Translationa & Clinical Research, Uniklinik RWTH Aachen, Aachen, Germany
Select one of your emails
You have multiple emails registered with Frontiers:
Notify me on publication
Please enter your email address:
If you already have an account, please login
You don't have a Frontiers account ? You can register here
Autoimmune bullous diseases (AIBDs) are acquired disorders characterized by autoantibodies targeting structural proteins of the skin and mucous membranes, resulting in blister formation. In pemphigus, pathogenic autoantibodies primarily directed against desmosomal adhesion proteins (desmoglein 1 and 3), disrupt epidermal cell-cell adhesion, leading to intraepidermal blister formation. In contrast, pemphigoid diseases are marked by subepidermal blistering due to autoantibodies against hemidesmosomal proteins, such as BP180 and BP230, located in the basement membrane zone. Diagnosis of AIBDs is based on clinical presentation, histolopathology, direct immunofluorescence, and serological analyses. Specific circulating autoantibodies can be identified using indirect immunofluorescence (IIF), which conventionally relies on animal-derived tissues, such as monkey esophagus, as substrates. This study aimed to develop a standardized in vitro diagnostic platform that eliminates the need for animal tissues. Human 3D skin models composed of dermal fibroblasts and epidermal keratinocytes were generated. Cryosections from these models were evaluated by IIF using sera from 34 patients diagnosed with either pemphigus vulgaris, pemphigus foliaceus, or bullous pemphigoid. As expected, sera from patients with pemphigus diseases produced the characteristic intercellular fluorescence pattern within the epidermis, while sera from pemphigoid patients exhibited staining along the basement membrane zone. These staining patterns precisely matched those obtained using monkey esophagus tissue. Notably, the 3D skin model demonstrated a significantly higher diagnostic sensitivity compared to the conventional monkey esophagus substrate. In summary, cryosections from human 3D skin models provide a sensitive and animal-free alternative for the serological diagnosis of AIBDs, accurately reproducing disease-specific immunofluorescence pattern.
Keywords: human 3D skin models, Autoimmune bullous diseases, Pemphigus Vulgaris, bullouspemphigoid, Indirect immunofluorescence, Serological Diagnosis
Received: 08 Jul 2025; Accepted: 08 Sep 2025.
Copyright: © 2025 Huth, Heise, Marquardt, Jansen, Kluwig, Schmidt, Albuscheit, Von Felbert, Translation Group, Jockenhoevel, Huth, Yazdi and Baron. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence: Laura Huth, Department of Dermatology and Allergology, Uniklinik RWTH Aachen, Aachen, Germany
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.